Bioavailability and bioequivalence are important concepts in pharmaceutical science. The document outlines topics to be covered by four groups on bioavailability, bioequivalence, and related terms. Group 1 will define key terms, discuss the purpose of bioavailability studies, and generic drug substitution. Group 2 will compare relative and absolute bioavailability and review methods and bases for assessing bioavailability. Group 3 will address criteria for establishing bioequivalence requirements and study waivers as well as designing and evaluating bioequivalence studies. Group 4 will discuss the clinical significance of bioequivalence studies and special concerns regarding bioavailability and bioequivalence assessments. The groups will report on their topics after a quiz the following Tuesday.